🇺🇸 FDA
Pipeline program

Escitalopram

LYG20230074

Unknown small_molecule active

Quick answer

Escitalopram for Major Depressive Disorder (MDD) is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Major Depressive Disorder (MDD)
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials